EntryPoint Capital LLC Takes Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

EntryPoint Capital LLC bought a new stake in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 22,793 shares of the company's stock, valued at approximately $528,000. EntryPoint Capital LLC owned about 0.09% of OrthoPediatrics as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of KIDS. KLP Kapitalforvaltning AS bought a new position in shares of OrthoPediatrics during the 4th quarter worth $79,000. American Century Companies Inc. boosted its position in OrthoPediatrics by 13.2% during the fourth quarter. American Century Companies Inc. now owns 26,410 shares of the company's stock worth $612,000 after purchasing an additional 3,072 shares during the period. HighTower Advisors LLC purchased a new position in shares of OrthoPediatrics in the fourth quarter worth about $268,000. Charles Schwab Investment Management Inc. increased its stake in shares of OrthoPediatrics by 2.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 136,234 shares of the company's stock worth $3,158,000 after purchasing an additional 3,800 shares in the last quarter. Finally, Mutual of America Capital Management LLC raised its position in shares of OrthoPediatrics by 57.1% in the fourth quarter. Mutual of America Capital Management LLC now owns 169,021 shares of the company's stock valued at $3,918,000 after purchasing an additional 61,412 shares during the period. 69.05% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on KIDS shares. Truist Financial reduced their price objective on shares of OrthoPediatrics from $28.00 to $25.00 and set a "hold" rating for the company in a research note on Wednesday, December 18th. Stifel Nicolaus decreased their price objective on OrthoPediatrics from $40.00 to $32.00 and set a "buy" rating on the stock in a research note on Wednesday, March 5th. Finally, Needham & Company LLC reissued a "buy" rating and set a $42.00 price objective on shares of OrthoPediatrics in a report on Wednesday, March 5th.

Remove Ads

Insider Activity

In other news, General Counsel Daniel J. Gerritzen sold 5,310 shares of the company's stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total transaction of $132,006.60. Following the completion of the transaction, the general counsel now directly owns 110,767 shares of the company's stock, valued at approximately $2,753,667.62. This represents a 4.57 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO David R. Bailey sold 6,620 shares of the company's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total value of $164,573.20. Following the transaction, the chief executive officer now directly owns 319,155 shares of the company's stock, valued at $7,934,193.30. The trade was a 2.03 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 23,732 shares of company stock worth $589,978. 31.80% of the stock is currently owned by corporate insiders.

OrthoPediatrics Price Performance

NASDAQ:KIDS traded down $0.01 during trading hours on Friday, hitting $24.74. The stock had a trading volume of 125,062 shares, compared to its average volume of 198,980. The firm has a market capitalization of $600.86 million, a price-to-earnings ratio of -20.11 and a beta of 1.22. OrthoPediatrics Corp. has a one year low of $21.02 and a one year high of $35.99. The company has a 50 day simple moving average of $24.75 and a two-hundred day simple moving average of $25.25. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last issued its quarterly earnings results on Tuesday, March 4th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.33) by $0.04. The firm had revenue of $52.67 million during the quarter, compared to the consensus estimate of $51.16 million. OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. During the same quarter last year, the company posted ($0.23) EPS. Research analysts forecast that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.